2018
DOI: 10.1097/mat.0000000000000614
|View full text |Cite
|
Sign up to set email alerts
|

Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation

Abstract: It is unclear whether pulmonary hemodynamics improvement with left ventricle unloading with left ventricular assist devices (LVADs) is sustained long term after heart transplant (HT). We sought to assess the effects on pulmonary vascular hemodynamics during continuous-flow (CF-LVAD) and pulsatile flow (PF-LVAD) support up to 5 years after HT. Invasive hemodynamics were evaluated before LVAD, before HT, and at 3 months, 1, and 3-5 years posttransplant. Thirty-eight patients were included in the study and divide… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 23 publications
0
6
0
Order By: Relevance
“…Specifically, frequent monitoring of PA pressures has been shown to significantly reduce long-term HF hospitalization rates as shown in both the CHAMPION [CardioMEMS™ Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in New York Heart Association Functional Class III Heart Failure Patients] clinical trial and in real-world experience. [9][10][11] Implantation of LVAD in patients previously implanted with a PA pressure sensor gives us an opportunity to describe longitudinal haemodynamic trends in LVAD patients. LVADs have been an increasingly utilized therapy for those with advanced HF and have resulted in improvements in patient functional status and quality of life, in addition to improved clinical outcomes relative to medical therapy.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Specifically, frequent monitoring of PA pressures has been shown to significantly reduce long-term HF hospitalization rates as shown in both the CHAMPION [CardioMEMS™ Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in New York Heart Association Functional Class III Heart Failure Patients] clinical trial and in real-world experience. [9][10][11] Implantation of LVAD in patients previously implanted with a PA pressure sensor gives us an opportunity to describe longitudinal haemodynamic trends in LVAD patients. LVADs have been an increasingly utilized therapy for those with advanced HF and have resulted in improvements in patient functional status and quality of life, in addition to improved clinical outcomes relative to medical therapy.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] While it is known that PA pressures decrease after both pulsatile and continuous flow LVAD implants, the magnitude, time course, and longterm sustainability of PA pressure changes is not well understood. [9][10][11] Implantation of LVAD in patients previously implanted with a PA pressure sensor gives us an opportunity to describe longitudinal haemodynamic trends in LVAD patients. Therefore, in this manuscript, we set out to characterize haemodynamic changes in the period leading up to LVAD implant and long-term follow-up thereafter.…”
Section: Introductionmentioning
confidence: 99%
“…Left ventricular assist device treatment has been demonstrated to reduce mPAP and sPAP with sustained effect three to 5 years following OHT. 22 Moreover, in a small study, LVAD support has been shown to progressively increase CO and decrease PAWP in the early period following LVAD implantation. Furthermore, markers of RV adaptation (i.e.…”
Section: Impact Of Lvad Pre-treatment On Ventricular Function Followi...mentioning
confidence: 99%
“…Long-term LVAD support resulted in significant improvement in pulmonary artery pressure regardless of the pump generation. The improvement in hemodynamics observed during LVAD support was sustained 3–5 years posttransplant [ 56 ]. In addition, recurrence rate of cardiac function deterioration among patients with LVAD explantation is 52% in 1 year and 80% in 3 years.…”
Section: Introductionmentioning
confidence: 99%